Companies: 10,795·Total market cap: $144.5T
Femasys Inc.

Femasys Inc.

FEMYNASDAQHealthcare● Active
$5.39
$-0.74(-12.04%)
Market Cap$18966116
P/E Ratio
52W High$22.2
52W Low$5.09
Overview

Femasys Inc. (FEMY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

femy · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Femasys Inc. (FEMY) measures how much investors pay for each dollar of the company's trailing earnings. FEMY's current PE ratio of N/A is calculated by dividing its stock price of $5.39 by its TTM earnings per share of -$3.72.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.26
Based on 2 analysts
EPS (TTM)
-$3.72
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Femasys Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Femasys Inc.
Femasys Inc.You
FEMY
$19MN/A-$3.72
Ainos, Inc.
Ainos, Inc.
AIMD
$9MN/A-$3.46
Apollomics, Inc.
Apollomics, Inc.
APLM
$15MN/A-$7.57
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp.
BCTX
$6MN/A-$19.37
Envoy Medical, Inc.
Envoy Medical, Inc.
COCH
$14MN/A-$1.21
Curis, Inc.
Curis, Inc.
CRIS
$6MN/A-$0.06
Daré Bioscience, Inc.
Daré Bioscience, Inc.
DARE
$18MN/A-$0.12

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-9.42
2024-12-31
FY2024
$-16.90
2023-12-31
FY2023
$-18.52
2022-12-31
FY2022
$-19.31
2021-12-31
FY2021
$-12.77
2020-12-31
FY2020
$-11.76
2019-12-31
FY2019
$-19.17

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Femasys Inc. (FEMY) measures how much investors pay for each dollar of the company's trailing earnings. FEMY's current PE ratio of N/A is calculated by dividing its stock price of $5.39 by its TTM earnings per share of -$3.72.

PE Ratio = Stock Price ÷ EPS (TTM)
= $5.39 ÷ -$3.72 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FEMY pe ratio · 6 questions

FEMY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.39 and TTM EPS of -$3.72. Data sourced from Financial Modeling Prep via FEMY's SEC 10-K and 10-Q filings.

FEMY PE ratioWhat is FEMY PE ratioCurrent PE ratio of FEMYFEMY PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Femasys Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09